Skip to main content

Featured

Bill C-30 Just Passed: 5 Ways It Changes Your Wallet in 2026

  Canadian Money Brief Bill C-30 just received Royal Assent — and it touches your gas tank, your TFSA neighbour the RRSP, your CPP statement, and your tax return all at once. Here are the five changes that actually matter for your wallet. 1. The Federal Fuel Excise Tax Is Suspended Until September 7 The federal excise tax on gasoline and diesel is paused from April 20 through September 7, 2026 — shaving 10 cents per litre off gas and 4 cents off diesel at the pump. The tax break also extends to aviation fuel. If you're road-tripping this summer, the savings show up automatically; you don't need to do anything to claim it. Just don't expect it to last past Labour Day weekend, since the suspension is scheduled to expire September 7. 2. Home Buyers' Plan Repayment Window Triples — From 2 Years to 5 If you used your RRSP to fund a down payment through the Home Buyers' Plan, the grace period before you have to start repaying yourself is extending from two years to five, ...
Post a Comment
Read more

article

Labels

Revolutionary Gene Therapy Restores Hearing in Deaf Toddler

 

In a remarkable medical breakthrough, an 18-month-old toddler named Opal Sandy has regained her hearing thanks to a pioneering gene therapy trial. Born deaf due to a rare genetic condition affecting the OTOF gene, which is responsible for producing a protein essential for hearing, Opal’s prospects for natural hearing were bleak. However, the innovative treatment at Cambridge University Hospitals in England has opened up a world of sound for her.

The procedure involved the infusion of a working copy of the OTOF gene into Opal’s right ear, a process that took a mere 16 minutes. Remarkably, within weeks, Opal began responding to loud noises, and after 24 weeks, she could hear whispers, indicating a near-normal level of hearing restoration.

Opal’s case is part of the Chord trial, which is recruiting more children from the UK, Spain, and the US to undergo similar treatment. The trial is being closely monitored, with participants followed up for five years to assess the long-term efficacy and safety of the therapy.

The success of this gene therapy is a beacon of hope for many suffering from genetic deafness, signaling the dawn of a new era in medical science where conditions once thought incurable are now within the realm of treatment. Opal’s story is not just a personal victory; it’s a milestone in genetic medicine, showcasing the incredible potential of gene therapy to change lives.

Labels:

Comments

Post a Comment